Bernardo Wealth Planning LLC Zynerba Pharmaceuticals, Inc. Transaction History

Bernardo Wealth Planning LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 21, 2023	BUY	$0.3 - $0.43 $12,000 - $17,200	40,000 Added 103.69%	78,578 $25,000
Q4 2022 Jan 30, 2023	BUY	$0.5 - $0.72 $4,054 - $5,838	8,109 Added 26.61%	38,578 $20,000
Q4 2021 Jan 27, 2022	BUY	$2.88 - $4.3 $4,752 - $7,095	1,650 Added 5.73%	30,469 $87,000
Q3 2021 Oct 15, 2021	BUY	$3.72 - $5.35 $5,952 - $8,560	1,600 Added 5.88%	28,819 $122,000
Q3 2020 Oct 23, 2020	BUY	$3.23 - $4.3 $2,584 - $3,440	800 Added 3.03%	27,219 $90,000
Q2 2019 Aug 13, 2019	BUY	$5.4 - $15.5 $5,400 - $15,500	1,000 Added 3.93%	26,419 $358,000
Q1 2019 May 08, 2019	BUY	$3.6 - $6.22 $4,600 - $7,949	1,278 Added 5.29%	25,419 $138,000
Q4 2018 Feb 14, 2019	BUY	$2.89 - $7.91 $69,767 - $190,955	24,141 New	24,141 $72,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Bernardo Wealth Planning LLC, based on Form 13F filings with the SEC.

Stay updated on Bernardo Wealth Planning LLC with notifications on news.